Skip to content

REVB

REVELATION BIOSCIENCES, INC.

NASDAQ · Healthcare · Biotechnology · US

$0.46
−4.42%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.18x
Price / sales
—
Price / cash flow
-0.20x

Enterprise value

Enterprise value
-$8.9M
EV / sales
—
EV / EBITDA
0.82x
EV / EBIT
0.79x
Market cap
$1.8M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026